SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 19.03 |
| Enterprise Value ($M) | -33.75 |
| Book Value ($M) | -4.01 |
| Book Value / Share | -0.33 |
| Price / Book | -4.74 |
| NCAV ($M) | -14.45 |
| NCAV / Share | -1.18 |
| Price / NCAV | -1.32 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.04 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -1.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.71 |
| Current Ratio | 4.71 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 68.63 |
| Assets | 79.07 |
| Liabilities | 83.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -66.10 |
| Net Income | -47.73 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -67.72 |
| Cash from Investing | 19.93 |
| Cash from Financing | 95.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Sio Capital Management, LLC | 0.00 | -100.00 | |
| 13G/A | Bristol Myers Squibb Co | 1.64 | -73.62 | |
| 13G/A | 5AM Ventures IV, L.P. | 0.00 | ||
| 13G/A | Temasek Holdings (Private) Ltd | 2.60 | ||
| 13G/A | ARCH Venture Fund VIII, L.P. |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,649 | 32,720 | 20.32 | |
| 37,716 | 114,983 | 32.80 | |
| 17,089 | 67,962 | 25.14 | |
| 35,626 | 91,462 | 38.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PTPI – Petros Pharmaceuticals, Inc. | PULM – Pulmatrix, Inc. |
| QLGN – Qualigen Therapeutics, Inc. | RENB – Renovaro Inc. |
| REVB – Revelation Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io